Wednesday, July 1, 2026

#biotech M&A

2 articles

Gilead Buys Ouro Medicines, Gives Spin-Off $500M to Build Global Inflammation Pipeline

Pharmaceuticals & Biotech

Gilead Buys Ouro Medicines, Gives Spin-Off $500M to Build Global Inflammation Pipeline

Salvado•Jun 11, 2026

Gilead and Europe's Lakefront Close $500M Ouro Deal in Cross-Atlantic Biotech Push

Pharmaceuticals & Biotech

Gilead and Europe's Lakefront Close $500M Ouro Deal in Cross-Atlantic Biotech Push

Salvado•Jun 7, 2026